Cargando…

Basement membrane defects in CD151-associated glomerular disease

BACKGROUND: CD151 is a cell-surface molecule of the tetraspanin family. Its lateral interaction with laminin-binding integrin ɑ3β1 is important for podocyte adhesion to the glomerular basement membrane (GBM). Deletion of Cd151 in mice induces glomerular dysfunction, with proteinuria and associated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Naylor, Richard W., Watson, Elizabeth, Williamson, Samantha, Preston, Rebecca, Davenport, J Bernard, Thornton, Nicole, Lowe, Martin, Williams, Maggie, Lennon, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587066/
https://www.ncbi.nlm.nih.gov/pubmed/35278129
http://dx.doi.org/10.1007/s00467-022-05447-y
_version_ 1784813828644536320
author Naylor, Richard W.
Watson, Elizabeth
Williamson, Samantha
Preston, Rebecca
Davenport, J Bernard
Thornton, Nicole
Lowe, Martin
Williams, Maggie
Lennon, Rachel
author_facet Naylor, Richard W.
Watson, Elizabeth
Williamson, Samantha
Preston, Rebecca
Davenport, J Bernard
Thornton, Nicole
Lowe, Martin
Williams, Maggie
Lennon, Rachel
author_sort Naylor, Richard W.
collection PubMed
description BACKGROUND: CD151 is a cell-surface molecule of the tetraspanin family. Its lateral interaction with laminin-binding integrin ɑ3β1 is important for podocyte adhesion to the glomerular basement membrane (GBM). Deletion of Cd151 in mice induces glomerular dysfunction, with proteinuria and associated focal glomerulosclerosis, disorganisation of GBM and tubular cystic dilation. Despite this, CD151 is not routinely screened for in patients with nephrotic-range proteinuria. We aimed to better understand the relevance of CD151 in human kidney disease. METHODS: Next-generation sequencing (NGS) was used to detect the variant in CD151. Electron and light microscopy were used to visualise the filtration barrier in the patient kidney biopsy, and immunoreactivity of patient red blood cells to anti-CD151/MER2 antibodies was performed. Further validation of the CD151 variant as disease-causing was performed in zebrafish using CRISPR-Cas9. RESULTS: We report a young child with nail dystrophy and persistent urinary tract infections who was incidentally found to have nephrotic-range proteinuria. Through targeted NGS, a novel, homozygous truncating variant was identified in CD151, a gene rarely reported in patients with nephrotic syndrome. Electron microscopy imaging of patient kidney tissue showed thickening of GBM and podocyte effacement. Immunofluorescence of patient kidney tissue demonstrated that CD151 was significantly reduced, and we did not detect immunoreactivity to CD151/MER2 on patient red blood cells. CRISPR-Cas9 depletion of cd151 in zebrafish caused proteinuria, which was rescued by injection of wild-type CD151 mRNA, but not CD151 mRNA containing the variant sequence. CONCLUSIONS: Our results indicate that a novel variant in CD151 is associated with nephrotic-range proteinuria and microscopic haematuria and provides further evidence for a role of CD151 in glomerular disease. Our work highlights a functional testing pipeline for future analysis of patient genetic variants. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a graphical abstract available at 10.1007/s00467-022-05447-y.
format Online
Article
Text
id pubmed-9587066
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95870662022-10-23 Basement membrane defects in CD151-associated glomerular disease Naylor, Richard W. Watson, Elizabeth Williamson, Samantha Preston, Rebecca Davenport, J Bernard Thornton, Nicole Lowe, Martin Williams, Maggie Lennon, Rachel Pediatr Nephrol Original Article BACKGROUND: CD151 is a cell-surface molecule of the tetraspanin family. Its lateral interaction with laminin-binding integrin ɑ3β1 is important for podocyte adhesion to the glomerular basement membrane (GBM). Deletion of Cd151 in mice induces glomerular dysfunction, with proteinuria and associated focal glomerulosclerosis, disorganisation of GBM and tubular cystic dilation. Despite this, CD151 is not routinely screened for in patients with nephrotic-range proteinuria. We aimed to better understand the relevance of CD151 in human kidney disease. METHODS: Next-generation sequencing (NGS) was used to detect the variant in CD151. Electron and light microscopy were used to visualise the filtration barrier in the patient kidney biopsy, and immunoreactivity of patient red blood cells to anti-CD151/MER2 antibodies was performed. Further validation of the CD151 variant as disease-causing was performed in zebrafish using CRISPR-Cas9. RESULTS: We report a young child with nail dystrophy and persistent urinary tract infections who was incidentally found to have nephrotic-range proteinuria. Through targeted NGS, a novel, homozygous truncating variant was identified in CD151, a gene rarely reported in patients with nephrotic syndrome. Electron microscopy imaging of patient kidney tissue showed thickening of GBM and podocyte effacement. Immunofluorescence of patient kidney tissue demonstrated that CD151 was significantly reduced, and we did not detect immunoreactivity to CD151/MER2 on patient red blood cells. CRISPR-Cas9 depletion of cd151 in zebrafish caused proteinuria, which was rescued by injection of wild-type CD151 mRNA, but not CD151 mRNA containing the variant sequence. CONCLUSIONS: Our results indicate that a novel variant in CD151 is associated with nephrotic-range proteinuria and microscopic haematuria and provides further evidence for a role of CD151 in glomerular disease. Our work highlights a functional testing pipeline for future analysis of patient genetic variants. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a graphical abstract available at 10.1007/s00467-022-05447-y. Springer Berlin Heidelberg 2022-03-12 2022 /pmc/articles/PMC9587066/ /pubmed/35278129 http://dx.doi.org/10.1007/s00467-022-05447-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Naylor, Richard W.
Watson, Elizabeth
Williamson, Samantha
Preston, Rebecca
Davenport, J Bernard
Thornton, Nicole
Lowe, Martin
Williams, Maggie
Lennon, Rachel
Basement membrane defects in CD151-associated glomerular disease
title Basement membrane defects in CD151-associated glomerular disease
title_full Basement membrane defects in CD151-associated glomerular disease
title_fullStr Basement membrane defects in CD151-associated glomerular disease
title_full_unstemmed Basement membrane defects in CD151-associated glomerular disease
title_short Basement membrane defects in CD151-associated glomerular disease
title_sort basement membrane defects in cd151-associated glomerular disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587066/
https://www.ncbi.nlm.nih.gov/pubmed/35278129
http://dx.doi.org/10.1007/s00467-022-05447-y
work_keys_str_mv AT naylorrichardw basementmembranedefectsincd151associatedglomerulardisease
AT watsonelizabeth basementmembranedefectsincd151associatedglomerulardisease
AT williamsonsamantha basementmembranedefectsincd151associatedglomerulardisease
AT prestonrebecca basementmembranedefectsincd151associatedglomerulardisease
AT davenportjbernard basementmembranedefectsincd151associatedglomerulardisease
AT thorntonnicole basementmembranedefectsincd151associatedglomerulardisease
AT lowemartin basementmembranedefectsincd151associatedglomerulardisease
AT williamsmaggie basementmembranedefectsincd151associatedglomerulardisease
AT lennonrachel basementmembranedefectsincd151associatedglomerulardisease